Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 May 31;5(3):dlad062.
doi: 10.1093/jacamr/dlad062. eCollection 2023 Jun.

Drivers of inappropriate antibiotic use in low- and middle-income countries

Idemudia Imonikhe Otaigbe  1 , Charles John Elikwu  1
Affiliations
Review

Drivers of inappropriate antibiotic use in low- and middle-income countries

Idemudia Imonikhe Otaigbe et al. JAC Antimicrob Resist. .

Abstract

Antimicrobial resistance (AMR) is a global security threat that accounts for about 700 000 deaths annually. Studies have shown that antimicrobial resistance could result in a 2% to 3.5% reduction in global Gross Domestic Product by 2050 and a loss of between 60 and 100 trillion US dollars, worth of economic output resulting in significant and widespread human suffering. Low- and middle-income countries (LMICs) will be worse hit by an unchecked rise of AMR. For example, it is predicted that AMR could kill about 4.1 million people in Africa by 2050 if it is not curbed. Similarly rising rates of AMR will lead to increased treatment costs and an inability to attain universal health coverage, in LMICs with fragile health systems. Sadly, AMR is driven by the inappropriate use of antimicrobials, especially antibiotics. Inappropriate antibiotic use is a pertinent problem in LMICs where regulatory frame works are weak. Inappropriate antibiotic use in LMICs is a multifaceted problem that cuts across clinical and veterinary medicine and agriculture. Therefore, efforts geared at curbing inappropriate antibiotic use in LMICs must identify the factors that drive this problem (i.e. inappropriate antibiotic use) in these countries. A clear knowledge of these factors will guide effective policy and decision making to curb inappropriate antibiotic use and ultimately AMR. The focus of this review is to discuss the factors that drive inappropriate antibiotic use in LMICs.

PubMed Disclaimer

Conflict of interest statement

None.

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Laxminarayan R, Matsoso P, Pant Set al. . Access to effective antimicrobials: a worldwide challenge. Lancet 2016; 387: 168–75. 10.1016/S0140-6736(15)00474-2 - DOI - PubMed
    1. Fraser A, Paul M, Almanasreh Net al. . Benefit of appropriate empirical antibiotic treatment: thirty-day mortality and duration of hospital stay. Am J Med 2006; 119: 970–6. 10.1016/j.amjmed.2006.03.034 - DOI - PubMed
    1. Janssen J, Afari-Asiedu S, Monnier Aet al. . Exploring the economic impact of inappropriate antibiotic use: the case of upper respiratory tract infections in Ghana. Antimicrob Resist Infect Control 2022; 11: 53. 10.1186/s13756-022-01096-w - DOI - PMC - PubMed
    1. O’ Neill J. Antimicrobial resistance: tackling a crisis for the health and wealth of nations. The review on antibiotic resistance. 2014https://wellcomecollection.org/works/rdpck35v
    1. Jonas OB, Irwin A, Berthe Fet al. . Drug-resistant infections: a threat to our economic future (Vol. 2): final report (English). HNP/Agriculture Global Antimicrobial Resistance Initiative Washington, D.C.: World Bank Group. 2017http://documents.worldbank.org/curated/en/323311493396993758/final-report.

LinkOut - more resources